Management of Chronic Spontaneous Urticaria Made Practical: What Every Clinician Should Know
The Journal of Allergy and Clinical Immunology: In Practice · 2025-09 · 13 (9) · 2252-2269
DOI: 10.1016/j.jaip.2025.07.021 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2025-09. Verfasst von Emek Kocatürk und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin…. Hauptthemen laut MEDLINE: Chronic Urticaria, Anti-Allergic Agents, Urticaria. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Despite its significant impact on quality of life, optimal management of chronic spontaneous urticaria remains challenging because of knowledge gaps regarding triggers, treatment response variability, and limited data for special populations. Second-generation H1-antihistamines are the first-line treatment and effective in approximately 50% of patients. For those who remain symptomatic, up-dosing up to fourfold is safe and recommended. However, prolonged ineffective antihistamine therapy should be avoided to prevent delayed disease control. In such cases, timely escalation to biologics, particularly omalizumab, is essential. Omalizumab remains the cornerstone of biologic therapy, offering rapid and sustained efficacy with an excellent safety profile. Personalized approaches involving dose escalation or interval adjustments further optimize outcomes. Cyclosporine A serves as an effective third-line option, particularly for autoimmune chronic spontaneous urticaria, but requires close monitoring because of dose-related adverse effects. Special considerations for children, pregnant individuals, and elderly people are discussed, reflecting the need for tailored approaches. Trigger avoidance, particularly nonsteroidal anti-inflammatory drugs, may aid management, although evidence is limited for many suspected exacerbating factors. Regular assessment of disease activity and control using validated tools such as the Urticaria Activity Score and Urticaria Control Test is essential for guiding treatment decisions and monitoring response. Updated international guidelines are anticipated to address emerging therapies and current knowledge gaps.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmac…
- Department of Medicine, Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
- Division of Allergy and Clinical Immunology, Erciyes University School of Medicine, Kayseri, Türkiye.
- Department of Dermatology/Allergology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
- Department of Dermatology, Erasmus MC, Rotterdam, the Netherlands; Centre for Human Drug Research, Leiden, the Netherlands.
- Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand; Pharmacoepidemiology and Statistical Research Center, Chiang Mai University, Chiang Mai, Thailand.
Zitieren
APA
Kocatürk, E., Chu, D. K., Türk, M., Röckmann, H., Van Doorn, M., Nochaiwong, S., & Zuberbier, T. (2025). Management of Chronic Spontaneous Urticaria Made Practical: What Every Clinician Should Know. The Journal of Allergy and Clinical Immunology: In Practice, 13(9), 2252-2269. https://doi.org/10.1016/j.jaip.2025.07.021
Vancouver
Kocatürk E, Chu DK, Türk M, Röckmann H, Van Doorn M, Nochaiwong S, et al. Management of Chronic Spontaneous Urticaria Made Practical: What Every Clinician Should Know. The Journal of Allergy and Clinical Immunology: In Practice. 2025;13(9):2252-2269. doi:10.1016/j.jaip.2025.07.021
BibTeX
@article{Kocatrk2025,
author = {Kocatürk, Emek and Chu, Derek K and Türk, Murat and Röckmann, Heike and Van Doorn, Martijn and Nochaiwong, Surapon and Zuberbier, Torsten},
title = {Management of Chronic Spontaneous Urticaria Made Practical: What Every Clinician Should Know},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2025},
volume = {13},
number = {9},
pages = {2252--2269},
doi = {10.1016/j.jaip.2025.07.021}
}
EUVIMED